EaglePicher Medical Power Announces New Li/CFx Battery ...( Enhanced design now features End-of-L...),Health

Enhanced design now features End-of-Life capability and longer life

PLANO, Texas, May 11 /PRNewswire/ -- EaglePicher Medical Power, LLC, a leading supplier of batteries for implantable medical devices, today announced the introduction of its enhanced Lithium Carbon Monofluoride (Li/CFx) battery technology with end-of-life capability superior to currently available products in the market. The technology includes a proprietary new Elective Replacement Indicator (ERI) / End of Life (EOL) Indicator to accurately predict battery depletion six months in advance, potentially requiring fewer replacement surgeries over time.

"This enhanced chemistry delivers several benefits - to device manufacturers, physicians and patients. In addition to the new end-of-life feature, this proprietary chemistry provides superior energy density for longer battery life," said Joe Marotta, vice president and general manager of EaglePicher Medical Power. "It gives us great pride to announce a technology that will help improve the lives of patients who rely on implantable medical devices."

The enhanced Li/CFx battery chemistry provides higher energy density for use in a variety of implantable applications including telemetry-capable pacemakers and ICDs, neurostimulation devices, drug pumps, body fluid pumps and monitors.

Benefits include:

• Proprietary ERI/EOL indicator for safe and predictable replacement prior to end of battery life
• Superior energy density enabling longer life or potentially smaller devices
• Excellent rate capability for rapid capacitor charging throughout most of the battery life
• Telemetry capability
• Elimination of the initial voltage delay commonly seen in Li/CFx batteries
• Low self-discharge

The new technology will be available in a numb
'/>"/>